NMPA/PMDA News
Page 1 • 3 itemsNavigate NMPA & PMDA drug approvals, regulatory updates, and market access strategies. Stay ahead in China & Japan pharma with critical intelligence.
Growth of Generics Market India: Impact of CDSCO Policy Changes on Pricing
This article examines the rapid growth of the generics market in India, highlighting the impact of CDSCO policy changes on drug pricing and accessibility.
PMDA SAKIGAKE Designation: Accelerating Regenerative Medicine Market Access in Japan
Explore the impact of PMDA SAKIGAKE Designation on speeding up access to regenerative medicine in Japan, enhancing treatment options for patients.
NMPA Priority Review Pathway: Accelerating Oncology & Rare Disease Drug Approvals
The NMPA Priority Review Pathway significantly speeds up the approval process for oncology and rare disease drugs, ensuring timely access to life-saving therapies.